AlloRx
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
The Foundation for Orthopaedics and Regenerative Medicine
Overview
AlloRx is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
AlloRx clinical trials
Explore related
Medical disclaimer. This page summarizes research about AlloRx for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.